Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.79 USD | +0.47% | -3.60% | +4.70% |
May. 22 | Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target | MT |
May. 16 | Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing | MT |
Official Publications
SEC Filing 10Q-2 | CO | |
Dividends | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 4K | CO | |
Dividends | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Changes in management and corporate officers | CO | |
Provisional calendar | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-3 | CO | |
Dividends | CO | |
SEC Filing 8K | CO | |
3rd quarter results | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Official Publications